Prevalence and assessment of breathlessness in the clinical setting

Expert Review of Respiratory Medicine

Volumn 8, Issue 2, 2014, Pages 151-161

  Johnson, Miriam J ^a   Currow, David C ^b   Booth, Sara ^c  

^a UNIVERSITY OF HULL   (United Kingdom)

^b FLINDERS UNIVERSITY   (Australia)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

assessment; breathlessness; dyspnea; palliation; prevalence

Indexed keywords

CHRONIC DISEASE; CLINICAL ASSESSMENT; DISTRESS SYNDROME; DYSPNEA; EMERGENCY CARE; FUNCTIONAL ASSESSMENT; HUMAN; PERSONAL EXPERIENCE; POPULATION; PREVALENCE; PRIMARY MEDICAL CARE; PROGNOSIS; QUALITY OF LIFE; REVIEW; TREATMENT PLANNING;

DYSPNEA; HUMANS; LUNG; PREDICTIVE VALUE OF TESTS; PREVALENCE; PROGNOSIS; RESPIRATORY FUNCTION TESTS; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 84896778432     PISSN: 17476348     EISSN: 17476356     Source Type: Journal    
DOI: 10.1586/17476348.2014.879530     Document Type: Review

References (71)

1. Thorsen H, Witt K, Hollnagel H, Malterud K. The purpose of the general practice consultation from the patient's perspective - theoretical aspects. Fam Pract 2001;18(6):638-433
2. Pendleton D, Schofield T, Tate P, Havelock P. The consultation: an approach to learning and teaching. OUP; Oxford, UK: 19844
3. Parshall MB, Schwartzstein RM, Adams L, et al. An official American Thoracic Society statement: update on the mechanisms, assessment, and management of dyspnea. Am J Respir Crit care Med 2012;185(4): 435-522
4. Barton R, English A, Nabb S, et al. A randomised trial of high vs low intensity training in breathing techniques for breathless patients with malignant lung disease: a feasibility study. Lung Cancer 2010;70:313-199
5. Booth S, Farquhar M, GyselsM, et al. The impact of a breathlessness intervention service (BIS) on the lives of patients with intractable dyspnea: a qualitative phase 1 study. Palliat Support Care 2006;4(3):287-933
6. Booth S, Bausewein C, Higginson I, Moosavi SH. Pharmacological treatment of refractory breathlessness. Expert Rev Respir Med 2009;3(1):21-366
7. Bredin M, Corner J, Krishnasamy M, et al. Multicentre randomised controlled trial of nursing intervention for breathlessness in patients with lung cancer. BMJ 1999; 318(7188):901-44
8. Bailey CD, Wagland R, Dabbour R, et al. An integrative review of systematic reviews related to the management of breathlessness in respiratory illnesses. BMC Pulm Med 2010;10:633
9. Abernethy AP, Wheeler JL. Total dyspnoea. Curr Opin Support Palliat Care 2008;2(2): 110-133
10. Booth S, Silvester S, Todd C. Breathlessness in cancer and chronic obstructive pulmonary disease: using a qualitative approach to describe the experience of patients and carers. Palliat Support Care 2003;1(4): 337-444
11. Seamark DA, Seamark CJ, Halpin DM. Palliative care in chronic obstructive pulmonary disease: a review for clinicians. J R Soc Med 2007;100(5):225-333
12. Exley C, Field D, Jones L, Stokes T. Palliative care in the community for cancer and end-stage cardiorespiratory disease: the views of patients, lay-carers and health care professionals. Palliat Med 2005;19(1):76-833
13. Gysels M, Higginson IJ. The experience of breathlessness: the social course of chronic obstructive pulmonary disease. J Pain Symptom Manage 2010;39(3):555-633
14. Walter F, Webster A, Scott S, Emery J. The Andersen model of total patient delay: a systematic review of its application in cancer diagnosis. J Health Serv Res Policy 2012;17(2):110-188
15. Currow DC, Plummer JL, Crockett A, Abernethy AP. A community population survey of prevalence and severity of dyspnea in adults. J Pain Symptom Manage 2009; 38(4):533-455
16. Frostad A, Soyseth V, Haldorsen T, et al. Respiratory symptoms and 30 year mortality from obstructive lung disease and pneumonia. Thorax 2006;61(11):951-66
17. Ho SF, O'Mahony MS, Steward JA, et al. Dyspnoea and quality of life in older people at home. Age Ageing 2001;30(2):155-99
18. Shin C, Lee S, Abbott RD, et al. Relationships between respiratory symptoms and FEV1 in men and women with normal lung function: the Korean Health and Genome Study. Lung 2005;183(5):301-99
19. Pedersen F, Mehlsen J, Raymond I, et al. Evaluation of dyspnoea in a sample of elderly subjects recruited from general practice. Int J Clin Pract 2007;61(9): 1481-911
20. Solano JP, Gomes B, Higginson IJ. A comparison of symptom prevalence in far advanced cancer, AIDS, heart disease, chronic obstructive pulmonary disease and renal disease. J Pain Symptom Manage 2006;31(1):58-699
21. Currow DC, Smith J, Davidson PM, et al. Do the trajectories of dyspnea differ in prevalence and intensity by diagnosis at the end of life? A consecutive cohort study. J Pain Symptom Manage 2010;39(4): 680-900
22. Ripamonti C. Management of dyspnea in advanced cancer patients. Support Care Cancer 1999;7(4):233-433
23. Edmonds P, Karlsen S, Khan S, Addington-Hall J. A comparison of the palliative care needs of patients dying from chronic respiratory diseases and lung cancer. Palliat Med 2001;15(4):287-955
24. Currow DC, Clark K, Mitchell GK, et al. Prospectively collected characteristics of adult patients, their consultations and outcomes as they report breathlessness when presenting to general practice in australia. PLoS One 2013;8(9):e748144
25. Frese T, Sobeck C, Herrmann K, Sandholzer H. Dyspnea as the reason for encounter in general practice. J Clin Med Res 2011;3(5):239-466
26. Johnson MJ, Bowden JA, Abernethy AP, Currow DC. To what causes do people attribute their chronic breathlessness? A population survey. J Palliat Med 2012; 15(7):744-500
27. National Hospital Ambulatory Medical Care Survey: 2010 emergency department summary tables. 2010.
28. Langlo NM, Orvik AB, Dale J, et al. The acute sick and injured patients: an overview of the emergency department patient population at a Norwegian University Hospital Emergency Department. Eur J Emerg Med 2013. [Epub ahead of print]]
29. Wallace EM, Cooney MC, Walsh J, et al. Why do palliative care patients present to the emergency department? Avoidable or unavoidable? Am J Hosp Palliat Care 2013; 30(3):253-66
30. Hammond EC. Some preliminary findings on physical complaints from a prospective study of 1.064.004 men and women. Am J Public Health Nations Health 1964;54: 11-233
31. Geraci JM, Tsang W, Valdres RV, Escalante CP. Progressive disease in patients with cancer presenting to an emergency room with acute symptoms predicts short-term mortality. Support Care Cancer 2006;14(10):1038-455
32. Ahmed T, Steward JA, O'Mahony MS. Dyspnoea and mortality in older people in the community: a 10-year follow-up. Age Ageing 2012;41(4):545-99
33. Parshall MB, Welsh JD, Brockopp DY, et al. Dyspnea duration, distress, and intensity in emergency department visits for heart failure. Heart Lung 2001;30(1):47-566
34. Parshall MB, Doherty GS. Predictors of emergency department visit disposition for patients with chronic obstructive pulmonary disease. Heart Lung 2006;35(5):342-500
35. Saracino A, Weiland TJ, Jolly B, Dent AW. Verbal dyspnoea score predicts emergency department departure status in patients with shortness of breath. Emerg Med Australas 2010;22(1):21-99
36. Frostad A, Soyseth V, Andersen A, Gulsvik A. Respiratory symptoms as predictors of all-cause mortality in an urban community: a 30-year follow-up. J Intern Med 2006;259(5):520-99
37. Banzett RB, Howell MD, O'Donnell CR, et al. Dyspnea prevalence and risk of adverse event in a general hospital population. B27. Patient-reported outcomes: symptoms and quality of life; 2013; p. A25088
38. Laveneziana P, Garcia G, Joureau B, et al. Dynamic respiratory mechanics and exertional dyspnoea in pulmonary arterial hypertension. Eur Respir J 2013;41(3): 578-877
39. Pratter MR, Abouzgheib W, Akers S, et al. An algorithmic approach to chronic dyspnea. Respir Med 2011;105(7):1014-211
40. Bausewein C, Booth S, Higginson IJ. Measurement of dyspnoea in the clinical rather than the research setting. Curr Opin Support Palliat Care 2008; 2(2):95-99
41. Dorman S, Byrne A, Edwards A. Which measurement scales should we use to measure breathlessness in palliative care? A systematic review. Palliat Med 2007; 21(3):177-911
42. Yorke J, Moosavi SH, Shuldham C, Jones PW. Quantification of dyspnoea using descriptors: development and initial testing of the Dyspnoea-12. Thorax 2010;65(1): 21-66
43. Meek PM, Banzett R, Parshall MB, et al. Reliability and validity of the multidimensional dyspnea profile. Chest 2012;141(6):1546-533
44. Parshall MB, Meek PM, Sklar D, et al. Test-retest reliability of multidimensional dyspnea profile recall ratings in the emergency department: a prospective, longitudinal study. BMC Emerg Med 2012; 12(1):66
45. Lansing RW, Gracely RH, Banzett RB. The multiple dimensions of dyspnea: review and hypotheses. Respir Physiol Neurobiol 2009; 167(1):53-600
46. Mularski RA, Campbell ML, Asch SM, et al. A review of quality of care evaluation for the palliation of dyspnea. Am J Respir Crit care Med 2010;181(6):534-88
47. Yorke J, Russell AM, Swigris J, et al. Assessment of dyspnea in asthma: validation of The Dyspnea-12. J Asthma 2011;48(6): 602-88
48. Abernethy AP, Zafar SY, Uronis H, et al. Validation of the patient care monitor (version 2.0): a review of system assessment instrument for cancer patients. J Pain Symptom Manage 2010;40(4):545-588
49. American Medical Association. PCPI- and PCPI approved quality measures. American Medical Association; IL, USA: 2013.
50. National Report on Patient Outcomes in Palliative Care in Australia, July-December 2012. 2013. http://ahsri.uow.edu.au/ content/groups/public/@web/ @chsd/@pcoc/ documents/doc/uow148641.pdf [Last accessed 13 September 2013]
51. Johnson MJ, Bland JM, Oxberry SG, et al. Clinically important differences in the intensity of chronic refractory breathlessness. J Pain Symptom Manage 2013;46(6): 957-633
52. Oxberry SG, Bland JM, Clark AL, et al. Minimally clinically important difference (MCID) in chronic breathlessness: every little helps. Am Heart J 2012;164(2):229-355
53. Currow DC, Abernethy AP, Johnson MJ. Activity as a measure of symptom control. J Pain Symptom Manage 2012;44(5):e1-22
54. Moy ML, Reilly JJ, Ries AL, et al. Multivariate models of determinants of health-related quality of life in severe chronic obstructive pulmonary disease. J Rehabil Res Dev 2009;46(5):643-544
55. Gruffydd-Jones K, Marsden HC, Holmes S, et al. Utility of COPD assessment test (CAT) in primary care consultations: a randomised controlled trial. Prim Care Respir J 2013;22(1):37-433
56. Schunemann HJ, Goldstein R, Mador MJ, et al. A randomised trial to evaluate the self-administered standardised chronic respiratory questionnaire. Eur Respir J 2005;25(1):31-400
57. Jones PW, Quirk FH, Baveystock CM. The St George's respiratory questionnaire. Respir Med 1991;85(Suppl B):25-311
58. Gysels M, Higginson IJ. Access to services for patients with chronic obstructive pulmonary disease: the invisibility of breathlessness. J Pain Symptom Manage 2008;36(5):451-600
59. Tod AM, Joanne R. Overcoming delay in the diagnosis of lung cancer: a qualitative study. Nurs Stand 2010;24(31):35-433
60. NHS Employers. Quality and outcomes framework guidance for GMS contract 2013/2014. NHS Employers; 2013. http:// www.nhsemployers.org/Aboutus/ Publications/Pages/qof-2013-14.aspx [Last accessed 08 January 2014]
61. The Criteria Committee of the New York Heart Association. Nomenclature and criteria for diagnosis of diseases of the heart and great vessels. Little, Brown & Co; Boston, MA, USA: 1994. p. 253-66
62. Celli BR, Cote CG, Marin JM, et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 2004;350(10):1005-122
63. Pang PS, Zaman M. Airway management & assessment of dyspnea in emergency department patients with acute heart failure. Curr Emerg Hosp Med Rep 2013;1(2): 122-55
64. Dyer DS, Khan AR, Mohammed TL, et al. R appropriateness criteria on chronic dyspnea: suspected pulmonary origin. J Thorac Imaging 2010;25(2):W21-33
65. Nunez S, Hexdall A, Guirre-Jaime A. Unscheduled returns to the emergency department: an outcome of medical errors? Qual Saf Health Care 2006;15(2):102-88
66. Koh HK, Brach C, Harris LM, Parchman ML. A proposed 'health literate care model' would constitute a systems approach to improving patients' engagement in care. Health Aff (Millwood) 2013;32(2): 357-677
67. Pinnock H, Kendall M, Murray SA, et al. Living and dying with severe chronic obstructive pulmonary disease: multiperspective longitudinal qualitative study. BMJ 2011;342:d1422
68. Jaarsma T, Beattie JM, Ryder M, et al. Palliative care in heart failure: a position statement from the palliative care workshop of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail 2009;11(5):433-433
69. End of life care strategy - promoting high quality care for all adults at the end of life. Available from: http://www dh gov uk/en/ Publicationsandstatistics/Publications/ PublicationsPolicyAndGuidance/ DH-086277 [Last accessed 25 Feb 2013]
70. Roberts DK, Thorne SE, Pearson C. The experience of dyspnea in late-stage cancer. Patients' and nurses' perspectives. Cancer Nurs 1993;16(4):310-200
71. Morrison RS, Meier DE. The National Palliative Care Research Center and the Center to Advance Palliative Care: a partnership to improve care for persons with serious illness and their families. J Pediatr Hematol Oncol 2011;33(Suppl 2): S126-311